Thyroid Cancer: What Are the Latest Advances in Treatment?

Thyroid cancer is usually a highly treatable malignancy with overall five-year survival rates over 98%. Many patients with thyroid cancer go on to live for several decades after their disease is cured.

By
September 29, 2026
6 min

Keck Medicine of USC

Original Source(s)

Keck Medicine Of USC

Thyroid Cancer: What Are the Latest Advances in Treatment?

by
September 29, 2026

Related Content

World Journal Of Urology

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation

by J. Gómez Rivas, L. Fernández Hernández, L. Turpin, A. Peyrottes, M. Rouprêt
September 29, 2026

Jama Network Open

Sex, Age, and Tumor Genetics to Inform Risk Stratification in Papillary Thyroid Cancer

by Carmelo Nucera
September 29, 2026

Baptist Health South Florida

A New Era for Pancreatic Cancer: How Baptist Health Research Helped Get Us Here

Pancreatic adenocarcinoma, the most common form of pancreatic cancer, accounts for roughly 90 to 95 percent of cases. It's notoriously difficult to catch early, because symptoms often don't appear until the disease has already spread

by
September 24, 2026
11 min